PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsWound infection
MeSH D014946 - wound infection
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007239:Infections
1 Company
1 Drug
$
Success rate
D014946: 
Wound infection
30 Companies
7 Drugs
$
Success rate
D013530:Surgical wound infection
86 Companies
15 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCloxacillin Cloxacillin  1982-01-01   
Oxacillin Oxacillin  1982-01-01   
GSKOxacillin Bactocill  1982-01-01   
Cloxacillin Cloxapen  1982-01-01   
Nafcillin Nallpen  1982-01-01   
SandozNafcillin Nafcillin  1984-08-02   
Oxacillin Oxacillin  1982-01-01   
WyethNafcillin Unipen  1986-12-16   
King PharmaceuticalsSilver sulfadiazine Silvadene  1982-01-01   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
44%
4/9
Phase 2
69%
11/16
Phase 3
57%
17/30
Approved: 6Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Mafenide
GSK
Cloxacillin
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use